Efficacy of Digital Problem Solving Application in Reduction of Anxiety, Depression and Substance Use Disorder Symptoms
- Sponsor
- 7 Generation Games
- Study ID
- NCT06346431
- Phase
- EARLY_PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Anxiety
- Depressive Symptoms
- Substance Use Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- DSPT - Digital Support for Problem-solving Therapy — COMBINATION_PRODUCTMobile app breaking major treatment and social needs into subtasks, providing information, prompts and in-app payment to complete those tasks.
Study Details
The focus of this study is the impact of usage of a mobile application to support problem-solving therapy on symptoms of anxiety, depression and substance use.
Key Dates
- First listed
- Apr 4, 2024
- Start date
- Mar 31, 2026
- Status verified
- Mar 2024
- Primary completion
- Nov 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: App Intervention groupA project coordinator will meet with the participant to assist in installing the app on device and provide instruction in use. Participants will be able to access support from the app continuously. When in proximity, during service hours to an organization meeting needs identified by the individual, the app will prompt to take action. Data will be collected on symptoms at baseline, three and six months post.
- No Intervention: Control groupData will be collected on symptoms at baseline, three and six months post. As individuals have a diagnosis of mental illness they may be receiving "Treatment as usual" for their reservation/ service provider, but no additional services will be provided by the sponsor.
Primary Outcome Measure
Generalized Anxiety Disorder Scale-7 [ Time Frame: Six months ]
Central Contacts
- AnnMaria Demars, Ph.D.3107179089
- Maria Burns Ortiz, BA2604021172
Related Studies
- Evaluation of the PACE/PACENET BHL Clinical ProgramRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Creatine for Depressed Male and Female Methamphetamine UsersPHASE3 · Recruiting · Montana State University · Missoula, Montana
- The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and TeensNot Yet Recruiting · Johns Hopkins University · Baltimore, Maryland
- Project I Test: Implementing HIV Testing in Opioid Treatment ProgramsRecruiting · Columbia University · New York, New York